ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Fujifilm Diosynth Biotechnologies is investing $1.2 billion at its large-scale cell culture facility in Holly Springs, North Carolina, which will bring total investment at the site to $3.2 billion. Included in the new investment will be eight mammalian cell culture reactors, each with 20,000 L in volume. Fujifilm had already been planning eight reactors of the same size. The new reactors will be completed by 2028.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X